Richard A Young insider trades

Open-market stock purchases and sales by Richard A Young, Director at Camp4 Therapeutics Corp, from SEC Form 4 filings since Apr 19, 2010.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +130%.

Recent trades

DateStockTradeValue
Jun 10, 2026CAMP Camp4 Therapeutics CorpBought (not open market)—

Companies traded

  • CAMP Camp4 Therapeutics Corp: 1 buy, last Jun 10, 2026
  • SYRS Syros Pharmaceuticals, Inc: 19 sales, last Sep 16, 2024
  • OMGA Omega Therapeutics, Inc: 6 sales, last Jun 20, 2024
  • ENZN Enzon Pharmaceuticals Inc: 1 sale, last Jan 2, 2013

Get free alerts when Richard A Young files a new trade →